With so many changes at AngioSoma, Inc. over the last month, we wanted to update our September 2016 shareholder presentation to correctly reflect what AngioSoma, Inc. has been doing. We have made the November 2016 AngioSoma, Inc. Shareholder Presentation available in both the PDF version and embedded here in its Microsoft PowerPoint version: © 2016 by Read more about November 2016 Shareholder Presentation[…]
Many of our current shareholders have many questions as to what AngioSoma, Inc. is doing, so we are making a shareholder presentation available (the PDF version available here) to all of our shareholders. We intend to update this as we progress in our business plan. © 2016 by AngioSoma, Inc., all rights reserved.
As a publicly traded organization, AngioSoma, Inc. is an SEC reporting company, which requires the company to follow the mandates of Regulation Fair Disclosure (also known as “Regulation FD” or “Reg FD“). Regulation FD requires public companies to “disclosure material information to all investors at the same time.” To that extent, AngioSoma, Inc. provides all Read more about What type of news is provided by the company on Twitter?[…]
The stock is quoted on OTC Markets’ Venture Market (OTCQB) under the symbol SOAN.
This was taken from the company’s 10K for period ending September 30, 2015: “First Titan Corp., a Nevada corporation, was incorporated on September 16, 2010. Our year-end is September 30. We were formed to design and manufacture both panel and engineered/tooled custom vacuum formed instrument panels and wiring harnesses, required for the monitoring of any Read more about When was AngioSoma, Inc. founded and in what state is it incorporated?[…]